These data implicated that IL-8 secreted by MSC-ad led to increased BCRP protein expression and was responsible for reduced doxorubicin sensitivity in MDA-MB-231 triple negative breast cancer cells. The gene discussed is CXCL8; the disease is triple-negative breast carcinoma.